The emerging approach of the medication represents a exciting development in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatidepeptide691077.fitnell.com/83135895/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment